Kruh GD - Search Results

1

Multidrug resistance protein 4 protects bone marrow, thymus, spleen, and intestine from nucleotide analogue-induced damage.

Belinsky MG, Guo P, Lee K, Zhou F, Kotova E, Grinberg A, Westphal H, Shchaveleva I, Klein-Szanto A, Gallo JM, Kruh GD. Belinsky MG, et al. Among authors: kruh gd. Cancer Res. 2007 Jan 1;67(1):262-8. doi: 10.1158/0008-5472.CAN-06-2680. Cancer Res. 2007. PMID: 17210706

2

Analysis of methotrexate and folate transport by multidrug resistance protein 4 (ABCC4): MRP4 is a component of the methotrexate efflux system.

Chen ZS, Lee K, Walther S, Raftogianis RB, Kuwano M, Zeng H, Kruh GD. Chen ZS, et al. Among authors: kruh gd. Cancer Res. 2002 Jun 1;62(11):3144-50. Cancer Res. 2002. PMID: 12036927

3

Characterization of the drug resistance and transport properties of multidrug resistance protein 6 (MRP6, ABCC6).

Belinsky MG, Chen ZS, Shchaveleva I, Zeng H, Kruh GD. Belinsky MG, et al. Among authors: kruh gd. Cancer Res. 2002 Nov 1;62(21):6172-7. Cancer Res. 2002. PMID: 12414644

4

Characterization of the transport properties of human multidrug resistance protein 7 (MRP7, ABCC10).

Chen ZS, Hopper-Borge E, Belinsky MG, Shchaveleva I, Kotova E, Kruh GD. Chen ZS, et al. Among authors: kruh gd. Mol Pharmacol. 2003 Feb;63(2):351-8. doi: 10.1124/mol.63.2.351. Mol Pharmacol. 2003. PMID: 12527806

5

Transport of methotrexate, methotrexate polyglutamates, and 17beta-estradiol 17-(beta-D-glucuronide) by ABCG2: effects of acquired mutations at R482 on methotrexate transport.

Chen ZS, Robey RW, Belinsky MG, Shchaveleva I, Ren XQ, Sugimoto Y, Ross DD, Bates SE, Kruh GD. Chen ZS, et al. Among authors: kruh gd. Cancer Res. 2003 Jul 15;63(14):4048-54. Cancer Res. 2003. PMID: 12874005

6

The MRP family of drug efflux pumps.

Kruh GD, Belinsky MG. Kruh GD, et al. Oncogene. 2003 Oct 20;22(47):7537-52. doi: 10.1038/sj.onc.1206953. Oncogene. 2003. PMID: 14576857 Review.

7

Analysis of the drug resistance profile of multidrug resistance protein 7 (ABCC10): resistance to docetaxel.

Hopper-Borge E, Chen ZS, Shchaveleva I, Belinsky MG, Kruh GD. Hopper-Borge E, et al. Among authors: kruh gd. Cancer Res. 2004 Jul 15;64(14):4927-30. doi: 10.1158/0008-5472.CAN-03-3111. Cancer Res. 2004. PMID: 15256465

8

Analysis of the in vivo functions of Mrp3.

Belinsky MG, Dawson PA, Shchaveleva I, Bain LJ, Wang R, Ling V, Chen ZS, Grinberg A, Westphal H, Klein-Szanto A, Lerro A, Kruh GD. Belinsky MG, et al. Among authors: kruh gd. Mol Pharmacol. 2005 Jul;68(1):160-8. doi: 10.1124/mol.104.010587. Epub 2005 Apr 6. Mol Pharmacol. 2005. PMID: 15814571

9

Physiological and pharmacological functions of Mrp2, Mrp3 and Mrp4 as determined from recent studies on gene-disrupted mice.

Kruh GD, Belinsky MG, Gallo JM, Lee K. Kruh GD, et al. Cancer Metastasis Rev. 2007 Mar;26(1):5-14. doi: 10.1007/s10555-007-9039-1. Cancer Metastasis Rev. 2007. PMID: 17273943 Review.

10

Contribution of Abcc10 (Mrp7) to in vivo paclitaxel resistance as assessed in Abcc10(-/-) mice.

Hopper-Borge EA, Churchill T, Paulose C, Nicolas E, Jacobs JD, Ngo O, Kuang Y, Grinberg A, Westphal H, Chen ZS, Klein-Szanto AJ, Belinsky MG, Kruh GD. Hopper-Borge EA, et al. Among authors: kruh gd. Cancer Res. 2011 May 15;71(10):3649-57. doi: 10.1158/0008-5472.CAN-10-3623. Cancer Res. 2011. PMID: 21576088 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

80 results

Search Page

Filters